Neutralizing monoclonal antibodies for early treatment of hospital‐acquired SARS‐CoV‐2 infection in hematologic patients

Efficacy of early treatment with anti‐SARS‐CoV‐2 spike protein monoclonal antibodies (mAbs) for nosocomial SARS‐CoV‐2 infection in hematologic patients is unknown. Retrospective, cohort study conducted in four Italian teaching hospitals. We included adult patients with hematologic malignancies and h...

Descripción completa

Detalles Bibliográficos
Autores principales: Bussini, Linda, Testi, Diletta, Tazza, Beatrice, Oltolini, Chiara, Mastaglio, Sara, Sepulcri, Chiara, Campoli, Caterina, Trapani, Filippo, Pasquini, Zeno, Zappulo, Emanuela, Bassetti, Matteo, Viale, Pierluigi, Mikulska, Malgorzata, Bartoletti, Michele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Haematologic Malignancy ‐ Lymphoid
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537893/
https://www.ncbi.nlm.nih.gov/pubmed/36248618
http://dx.doi.org/10.1002/jha2.554

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537893/
https://www.ncbi.nlm.nih.gov/pubmed/36248618
http://dx.doi.org/10.1002/jha2.554

Ejemplares similares